Innovative Clinical Solutions Inc. – Trademark Portfolio
Entity Type: 03
Innovative Clinical Solutions Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include COVALIS NUTRITION. The owner is based in New York, NY.
Suite 603
192 Lexington Avenue
New York, NY 10016
Showing of trademarks Trademarks
Trademark Classifications
Innovative Clinical Solutions Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Innovative Clinical Solutions Inc. have?
Innovative Clinical Solutions Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 8 abandoned.
What trademark classes does Innovative Clinical Solutions Inc. file in?
Innovative Clinical Solutions Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Innovative Clinical Solutions Inc.'s most well-known trademarks?
Innovative Clinical Solutions Inc.'s registered trademark portfolio includes well-known marks such as COVALIS NUTRITION. These are among 1 currently registered trademark in the portfolio.
What is Innovative Clinical Solutions Inc.'s trademark registration success rate?
Innovative Clinical Solutions Inc. has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.